Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03996148 · ClinicalTrials.gov registry record · Phase 4
Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques
A Phase 4 study, sponsored by The Cooper Health System.
- Completed
- Registry status
- Phase 4
- Development phase
- 21
- Enrollment target
NCT03996148 is a Phase 4 study that has completed, run by The Cooper Health System. The registered enrollment target is 21 participants.
The verdict
NCT03996148, a Phase 4 study, has completed, sponsored by The Cooper Health System.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 21 participants
- Enrollment target
Study Summary
The objective of this pilot study is to analyze the differences in time to first postoperative neurological examination (cranial nerve XII - tongue movement, movement of extremities) and intraoperative hemodynamic stability with three different general anesthetic techniques that are used for carotid endarterectomy. Carotid endarterectomy surgery removes the plaque and stenosis but has a 1-3% risk of periprocedural stroke or death. The ability to detect neurological abnormalities early after surgery is vital in this patient population to facilitate timely additional diagnostics or interventions if a potential stroke is detected. Anesthetic techniques that facilitate an earlier reliable neurological exam will thus greatly benefit this surgical patient population. The primary objective of this pilot study is to determine the time difference from end of surgery to first neurologic exam between three commonly used anesthetic methods for carotid endareterectomy.
Interventions
- DRUG Remifentanil, Propofol, and Desflurane
- DRUG Remifentanil, Dexmedetomidine, and Desflurane
- DRUG Remifentanil and Desflurane
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2017-09-29 |
| Est. Completion | 2018-09-19 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03996148
The ClinicalTrials.gov registry entry for NCT03996148 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is The Cooper Health System, which has 39 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Remifentanil, Propofol, and Desflurane is the first listed.
NCT03996148 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03996148 about?
NCT03996148 is a clinical study titled "Time to Post-Anesthesia Neurological Evaluation With Three Different Anesthetic Techniques". The objective of this pilot study is to analyze the differences in time to first postoperative neurological examination (cranial nerve XII - tongue movement, movement of extremities) and intraoperative hemodynamic stability with three different general anesthetic techniques that are used for carotid...
What is the current status of trial NCT03996148?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 21 participants. The study started on 2017-09-29. Estimated completion is 2018-09-19.
What interventions are being tested in trial NCT03996148?
The interventions under investigation include: Remifentanil, Propofol, and Desflurane (DRUG), Remifentanil, Dexmedetomidine, and Desflurane (DRUG), Remifentanil and Desflurane (DRUG).
Who is sponsoring clinical trial NCT03996148?
This trial is sponsored by The Cooper Health System, which has 39 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.